AIBT (Aibotics) Equity-to-Asset: -8.37 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Aibotics Equity-to-Asset?

Aibotics AIBT Equity-to-Asset is -8.37 as of Jun. 2026. The stock has 1 warning sign investors should review. Among 856 Travel & Leisure companies, Aibotics ranks worse than 99.3% on this metric.

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Aibotics's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $-4.60 Mil. Aibotics's Total Assets for the quarter that ended in Jun. 2026 was $0.55 Mil.

The historical rank and industry rank for Aibotics's Equity-to-Asset or its related term are showing as below:

AIBT' s Equity-to-Asset Range Over the Past 10 Years
Min: -8.37   Med: -0.72   Max: 1
Current: -8.37

During the past 8 years, the highest Equity to Asset Ratio of Aibotics was 1.00. The lowest was -8.37. And the median was -0.72.

AIBT's Equity-to-Asset is ranked worse than
99.3% of 856 companies
in the Travel & Leisure industry
Industry Median: 0.51 vs AIBT: -8.37

Aibotics  (OTCPK:AIBT) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Aibotics Equity-to-Asset Related Terms


Aibotics Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Aibotics's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aibotics Equity-to-Asset Chart

Aibotics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Equity-to-Asset
Get a 7-Day Free Trial 0.04 -2.30 -0.91 -2.33 -4.53

Aibotics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.55 -3.82 -4.53 -5.55 -8.37

AIBT vs SPQS, AVNI, TRUG: Equity-to-Asset Comparison

For the Leisure subindustry, Aibotics's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aibotics Equity-to-Asset vs Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, Aibotics's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Aibotics's Equity-to-Asset falls into.



Aibotics Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Aibotics's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Equity to Asset (A: Dec. 2025 )=Total Stockholders Equity/Total Assets
=-3.96/0.875
=-4.53

Aibotics's Equity to Asset Ratio for the quarter that ended in Jun. 2026 is calculated as

Equity to Asset (Q: Jun. 2026 )=Total Stockholders Equity/Total Assets
=-4.602/0.55
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Equity-to-Asset →
What does a Equity-to-Asset of -8.37 mean?
Aibotics (AIBT) has a Equity-to-Asset of -8.37 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Aibotics and its competitors. According to the industry distribution chart, Aibotics ranks #850 out of 856 companies in the Travel & Leisure industry, placing it in the top 99.3%.
Is Aibotics' Equity-to-Asset too high?
Aibotics' current Equity-to-Asset is -8.37. Based on the distribution chart, Aibotics ranks #850 out of 856 companies in the Travel & Leisure industry, which is in the bottom quartile relative to peers.
How does Aibotics' Equity-to-Asset compare to SPQS and AVNI?
According to the Travel & Leisure industry distribution chart, Aibotics ranks #850 out of 856 companies for Equity-to-Asset. This places Aibotics in the lower half of its industry. The industry median Equity-to-Asset is 0.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Travel & Leisure company?
The median Equity-to-Asset among Travel & Leisure companies is 0.51, based on 856 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Aibotics and its competitors. For the Travel & Leisure industry, the median Equity-to-Asset is 0.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aibotics's current Equity-to-Asset is -8.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aibotics stock overvalued right now?
Aibotics (AIBT) has a current Equity-to-Asset of -8.37. The current Equity-to-Asset is -8.37. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Aibotics (AIBT), the current Equity-to-Asset is -8.37 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aibotics Business Description

Address 100 SE 2nd Street, Suite 2000, Miami, FL, USA, 33131
Aibotics Inc is a holding company specializing in artificial intelligence and robotics. It promotes the study of psychedelics for the treatment of mental health issues and supports the creation of both natural and synthetic molecules for the development of appropriate treatments. Aibotics also intends to deploy technology from its parent company, in the collection of research and clinical data to further the study of the effects of psychedelics in the treatment of mental health issues.